These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17276950)

  • 1. Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays.
    Arihiro K; Umemura S; Kurosumi M; Moriya T; Oyama T; Yamashita H; Umekita Y; Komoike Y; Shimizu C; Fukushima H; Kajiwara H; Akiyama F
    Am J Clin Pathol; 2007 Mar; 127(3):356-65. PubMed ID: 17276950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories.
    Regitnig P; Reiner A; Dinges HP; Höfler G; Müller-Holzner E; Lax SF; Obrist P; Rudas M; Quehenberger F
    Virchows Arch; 2002 Oct; 441(4):328-34. PubMed ID: 12404057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer.
    Biesterfeld S; Veuskens U; Schmitz FJ; Amo-Takyi B; Böcking A
    Anticancer Res; 1996; 16(5A):2497-500. PubMed ID: 8917341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semi-automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer.
    Sharangpani GM; Joshi AS; Porter K; Deshpande AS; Keyhani S; Naik GA; Gholap AS; Barsky SH
    J Microsc; 2007 Jun; 226(Pt 3):244-55. PubMed ID: 17535263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of immunohistochemical staining for oestrogen receptor, progesterone receptor and HER-2 in breast core biopsies and subsequent excisions.
    Wood B; Junckerstorff R; Sterrett G; Frost F; Harvey J; Robbins P
    Pathology; 2007 Aug; 39(4):391-5. PubMed ID: 17676479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears.
    Krishnamurthy S; Dimashkieh H; Patel S; Sneige N
    Diagn Cytopathol; 2003 Dec; 29(6):309-14. PubMed ID: 14648786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stability of estrogen and progesterone receptor expression on breast carcinoma cells stored as PreservCyt suspensions and as ThinPrep slides.
    Tabbara SO; Sidawy MK; Frost AR; Brosky KR; Coles V; Hecht S; Radcliffe G; Sherman ME
    Cancer; 1998 Dec; 84(6):355-60. PubMed ID: 9915137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer.
    Sutela A; Vanninen R; Sudah M; Berg M; Kiviniemi V; Rummukainen J; Kataja V; Kärjä V
    Acta Oncol; 2008; 47(1):38-46. PubMed ID: 17851859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunohistochemical determination of hormonal receptors on cell-blocks from fine-needle cytopunctures of breast carcinoma].
    Briffod M; Le Doussal V; Spyratos F
    Bull Cancer; 2001 Oct; 88(10):1028-35. PubMed ID: 11713039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of fixation, processing and evaluation criteria on immunohistochemical detection of hormone receptors in breast cancer.
    Oyama T; Ishikawa Y; Hayashi M; Arihiro K; Horiguchi J
    Breast Cancer; 2007; 14(2):182-8. PubMed ID: 17485904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis.
    Hanley KZ; Siddiqui MT; Lawson D; Cohen C; Nassar A
    Diagn Cytopathol; 2009 Apr; 37(4):251-7. PubMed ID: 19217031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative assessment of proliferative activity and hormonal receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen.
    Railo M; Nordling S; Krogerus L; Sioris T; von Smitten K
    Diagn Cytopathol; 1996 Sep; 15(3):205-10. PubMed ID: 8955602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer.
    Neven P; Van Calster B; Van den Bempt I; Van Huffel S; Van Belle V; Hendrickx W; Decock J; Wildiers H; Paridaens R; Amant F; Leunen K; Berteloot P; Timmerman D; Van Limbergen E; Weltens C; Van den Bogaert W; Smeets A; Vergote I; Christiaens MR; Drijkoningen M
    Breast Cancer Res Treat; 2008 Jul; 110(1):153-9. PubMed ID: 17687649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.
    Parker RL; Huntsman DG; Lesack DW; Cupples JB; Grant DR; Akbari M; Gilks CB
    Am J Clin Pathol; 2002 May; 117(5):723-8. PubMed ID: 12090420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of oestrogen receptor negative progesterone receptor positive phenotype in Indian breast cancer: fact or fiction?
    Navani S; Bhaduri AS
    Indian J Pathol Microbiol; 2005 Apr; 48(2):199-201. PubMed ID: 16758664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.
    Brouckaert O; Pintens S; Van Belle V; Van Huffel S; Camerlynck E; Amant F; Leunen K; Smeets A; Berteloot P; Van Limbergen E; Decock J; Hendrickx W; Weltens C; Van den Bogaert W; Vanden Bempt I; Drijkoningen M; Paridaens R; Wildiers H; Vergote I; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2009 May; 115(2):349-58. PubMed ID: 18629635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An approach to preliminary studies of interlaboratory comparative results for estrogen and progesterone receptors.
    Tubbs RR
    J Cell Biochem Suppl; 1994; 19():36-9. PubMed ID: 7823603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interobserver agreement among pathologists for semiquantitative hormone receptor scoring in breast carcinoma.
    Cohen DA; Dabbs DJ; Cooper KL; Amin M; Jones TE; Jones MW; Chivukula M; Trucco GA; Bhargava R
    Am J Clin Pathol; 2012 Dec; 138(6):796-802. PubMed ID: 23161712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative immunohistochemical assay for hormonal receptors: technical aspects and biological significance.
    Esteban JM; Ahn C; Battifora H; Felder B
    J Cell Biochem Suppl; 1994; 19():138-45. PubMed ID: 7823586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.